By expenditures
| Name | Title | Type |
|---|---|---|
| Jennifer Claver | CFO, OUTSOURCED | Auditee |
| Ryan Engelstad | PARTNER | Auditee |
| Ryan Engelstad | SHAREHOLDER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 331183 | 2024 | 2024-12-05 | Bergankdv LTD | $3.60M |
| 295310 | 2023 | 2024-03-15 | Bergankdv LTD | $3.40M |
| 42091 | 2022 | 2023-02-19 | Baker Tilly US LLP | $3.70M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 42091 | 2022 | 2023-02-19 | 626278 | 2022-003 | Significant Deficiency | - | C |
| 42091 | 2022 | 2023-02-19 | 626277 | 2022-003 | Significant Deficiency | - | C |
| 42091 | 2022 | 2023-02-19 | 626276 | 2022-003 | Significant Deficiency | - | C |
| 42091 | 2022 | 2023-02-19 | 626275 | 2022-002 | - | - | I |
| 42091 | 2022 | 2023-02-19 | 626274 | 2022-001 | Significant Deficiency | Yes | L |
| 42091 | 2022 | 2023-02-19 | 626273 | 2022-002 | - | - | I |
| 42091 | 2022 | 2023-02-19 | 626272 | 2022-001 | Significant Deficiency | Yes | L |
| 42091 | 2022 | 2023-02-19 | 626271 | 2022-002 | - | - | I |
| 42091 | 2022 | 2023-02-19 | 626270 | 2022-001 | Significant Deficiency | Yes | L |
| 42091 | 2022 | 2023-02-19 | 49836 | 2022-003 | Significant Deficiency | - | C |
| 42091 | 2022 | 2023-02-19 | 49835 | 2022-003 | Significant Deficiency | - | C |
| 42091 | 2022 | 2023-02-19 | 49834 | 2022-003 | Significant Deficiency | - | C |
| 42091 | 2022 | 2023-02-19 | 49833 | 2022-002 | - | - | I |
| 42091 | 2022 | 2023-02-19 | 49832 | 2022-001 | Significant Deficiency | Yes | L |
| 42091 | 2022 | 2023-02-19 | 49831 | 2022-002 | - | - | I |
| 42091 | 2022 | 2023-02-19 | 49830 | 2022-001 | Significant Deficiency | Yes | L |
| 42091 | 2022 | 2023-02-19 | 49829 | 2022-002 | - | - | I |
| 42091 | 2022 | 2023-02-19 | 49828 | 2022-001 | Significant Deficiency | Yes | L |